Electromed (ELMD) Operating Margin Growth (3y) (2013 - 2026)

Electromed (ELMD) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -343.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 78.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -283.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,505.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,016.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -184.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Electromed 313.26 Mn 296.27 Mn 14.64 Mn 1,036.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,036.00
Dec 31, 2025 829.00
Sep 30, 2025 1,540.00
Jun 30, 2025 1,309.00
Mar 31, 2025 513.00
Dec 31, 2024 514.00
Sep 30, 2024 783.00
Jun 30, 2024 886.00
Mar 31, 2024 1,051.00
Dec 31, 2023 -14.00
Sep 30, 2023 -713.00
Jun 30, 2023 -777.00
Mar 31, 2023 -53.00
Dec 31, 2022 -747.00
Sep 30, 2022 -1,583.00
Jun 30, 2022 -1,291.00
Mar 31, 2022 224.00
Dec 31, 2021 208.00
Sep 30, 2021 261.00
Jun 30, 2021 -918.00